$1.82 Billion is the total value of Bellevue Group AG's 138 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 22.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALGN | Buy | ALIGN TECHNOLOGY INC | $95,159,000 | +46.2% | 334,679 | +7.7% | 5.24% | +22.3% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $86,157,000 | +29.6% | 150,999 | +8.8% | 4.74% | +8.5% |
| ABT | Buy | ABBOTT LABS | $83,185,000 | +17.8% | 1,040,587 | +6.6% | 4.58% | -1.4% |
| ILMN | Buy | ILLUMINA INC | $80,064,000 | +6.0% | 257,696 | +2.3% | 4.40% | -11.3% |
| TDOC | Buy | TELADOC HEALTH INC | $76,411,000 | +43.5% | 1,374,294 | +28.0% | 4.20% | +20.1% |
| ANTM | Buy | ANTHEM INC | $73,185,000 | +19.8% | 255,017 | +9.6% | 4.03% | +0.2% |
| DHR | Buy | DANAHER CORPORATION | $45,122,000 | +31.4% | 341,784 | +2.7% | 2.48% | +10.0% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $44,041,000 | +17.9% | 1,147,487 | +8.6% | 2.42% | -1.3% |
| HUM | Buy | HUMANA INC | $40,559,000 | +80.0% | 152,477 | +93.8% | 2.23% | +50.6% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $38,230,000 | +18.3% | 267,438 | +2.6% | 2.10% | -0.9% |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $33,198,000 | +31.2% | 695,824 | +42.9% | 1.83% | +9.8% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $32,845,000 | -0.7% | 132,837 | +0.0% | 1.81% | -17.0% |
| BDX | Buy | BECTON DICKINSON & CO | $32,208,000 | +17.3% | 128,972 | +5.8% | 1.77% | -1.8% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $30,979,000 | +28.2% | 161,912 | +2.6% | 1.70% | +7.3% |
| WCG | Buy | WELLCARE HEALTH PLANS INC | $28,976,000 | +47.5% | 107,419 | +29.1% | 1.59% | +23.4% |
| CI | New | CIGNA CORP NEW | $26,641,000 | – | 165,657 | +100.0% | 1.47% | – |
| QGEN | Buy | QIAGEN NV | $25,107,000 | +67.4% | 617,194 | +41.8% | 1.38% | +40.1% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $24,980,000 | +52.7% | 267,305 | +19.1% | 1.37% | +27.7% |
| BAX | Buy | BAXTER INTL INC | $23,838,000 | +42.3% | 293,174 | +15.2% | 1.31% | +19.1% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $23,136,000 | +52.6% | 171,150 | +9.9% | 1.27% | +27.7% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $21,520,000 | +13.2% | 116,989 | +2.0% | 1.18% | -5.3% |
| ABC | Buy | AMERISOURCEBERGEN CORP | $19,912,000 | +8.5% | 250,398 | +1.5% | 1.10% | -9.2% |
| ESPR | Buy | ESPERION THERAPEUTICS INC NEW | $19,896,000 | -4.3% | 495,547 | +9.6% | 1.10% | -19.9% |
| FIT | Buy | FITBIT INCcl a | $19,352,000 | +21.0% | 3,268,934 | +1.6% | 1.06% | +1.2% |
| HCM | Buy | HUTCHISON CHINA MEDITECH LTDsponsored adr | $18,296,000 | +80.0% | 598,310 | +35.9% | 1.01% | +50.7% |
| EVH | Buy | EVOLENT HEALTH INCcl a | $17,716,000 | +1861.9% | 1,408,237 | +3010.8% | 0.98% | +1552.5% |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $17,564,000 | +52.5% | 1,286,748 | +14.5% | 0.97% | +27.6% |
| ABMD | Buy | ABIOMED INC | $16,961,000 | +34.4% | 59,389 | +53.0% | 0.93% | +12.4% |
| GNMK | Buy | GENMARK DIAGNOSTICS INC | $16,683,000 | +71.7% | 2,353,067 | +17.7% | 0.92% | +43.7% |
| PRAH | Buy | PRA HEALTH SCIENCES INC | $16,489,000 | +26.0% | 149,507 | +5.1% | 0.91% | +5.5% |
| LIVN | Buy | LIVANOVA PLC | $16,236,000 | +39.2% | 166,956 | +30.9% | 0.89% | +16.4% |
| DXCM | Buy | DEXCOM INC | $15,619,000 | +67.6% | 131,146 | +68.6% | 0.86% | +40.1% |
| ZBH | Buy | ZIMMER BIOMET HLDGS INC | $14,679,000 | +53.7% | 114,951 | +24.8% | 0.81% | +28.7% |
| WBA | Buy | WALGREENS BOOTS ALLIANCE INC | $14,666,000 | -3.7% | 231,802 | +4.0% | 0.81% | -19.4% |
| QDEL | Buy | QUIDEL CORP | $14,638,000 | +139.8% | 223,580 | +78.9% | 0.80% | +100.7% |
| NKTR | Buy | NEKTAR THERAPEUTICS | $14,449,000 | +68.3% | 430,026 | +64.6% | 0.80% | +40.7% |
| AKCA | Buy | AKCEA THERAPEUTICS INC | $14,290,000 | +3.5% | 504,411 | +10.1% | 0.79% | -13.4% |
| BGNE | Buy | BEIGENE LTDsponsored adr | $13,490,000 | +15.0% | 102,200 | +22.2% | 0.74% | -3.8% |
| IART | Buy | INTEGRA LIFESCIENCES HLDGS C | $12,389,000 | +88.4% | 222,350 | +52.5% | 0.68% | +57.9% |
| GMED | Buy | GLOBUS MED INCcl a | $11,785,000 | +77.9% | 238,510 | +55.9% | 0.65% | +49.0% |
| OMCL | Buy | OMNICELL INC | $11,628,000 | +75.8% | 143,839 | +33.1% | 0.64% | +47.1% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $10,636,000 | +29.5% | 38,858 | +5.9% | 0.58% | +8.3% |
| XENT | Buy | INTERSECT ENT INC | $10,558,000 | +57.8% | 328,387 | +38.3% | 0.58% | +32.0% |
| MOH | Buy | MOLINA HEALTHCARE INC | $10,198,000 | +58.4% | 71,840 | +29.7% | 0.56% | +32.6% |
| CNC | Buy | CENTENE CORP DEL | $9,292,000 | -10.6% | 174,988 | +94.2% | 0.51% | -25.2% |
| AVDR | New | AVEDRO INC | $9,203,000 | – | 750,000 | +100.0% | 0.51% | – |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $9,066,000 | +131.4% | 526,162 | +71.6% | 0.50% | +93.4% |
| QTRX | Buy | QUANTERIX CORP | $9,024,000 | +72.4% | 349,359 | +22.2% | 0.50% | +44.5% |
| IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $8,827,000 | +51.6% | 117,761 | +40.5% | 0.49% | +26.9% |
| HMSY | Buy | HMS HLDGS CORP | $8,616,000 | +41.3% | 290,977 | +34.2% | 0.47% | +18.2% |
| GH | Buy | GUARDANT HEALTH INC | $8,410,000 | +105.0% | 109,652 | +0.5% | 0.46% | +71.5% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $8,377,000 | +47.6% | 20,400 | +34.2% | 0.46% | +23.6% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $8,099,000 | +114.9% | 127,541 | +28.5% | 0.45% | +79.8% |
| NVRO | Buy | NEVRO CORP | $8,026,000 | +153.4% | 128,402 | +57.7% | 0.44% | +112.5% |
| HCA | Buy | HCA HEALTHCARE INC | $7,875,000 | +34.5% | 60,397 | +28.4% | 0.43% | +12.5% |
| INSP | Buy | INSPIRE MED SYS INC | $6,990,000 | +78.6% | 123,105 | +32.9% | 0.38% | +49.8% |
| CSLT | Buy | CASTLIGHT HEALTH INCcl b | $6,827,000 | +197.0% | 1,820,470 | +71.8% | 0.38% | +149.0% |
| INGN | Buy | INOGEN INC | $6,650,000 | +60.9% | 69,727 | +109.4% | 0.37% | +34.6% |
| VEEV | Buy | VEEVA SYS INC | $6,611,000 | +94.3% | 52,110 | +36.8% | 0.36% | +62.5% |
| TRHC | Buy | TABULA RASA HEALTHCARE INC | $6,514,000 | +16.3% | 115,462 | +31.4% | 0.36% | -2.7% |
| IDXX | Buy | IDEXX LABS INC | $6,127,000 | +35.5% | 27,402 | +12.7% | 0.34% | +13.5% |
| MDSO | Buy | MEDIDATA SOLUTIONS INC | $5,162,000 | +55.6% | 70,474 | +43.2% | 0.28% | +30.3% |
| VCRA | Buy | VOCERA COMMUNICATONS INC | $5,004,000 | +285.8% | 158,214 | +380.2% | 0.28% | +223.5% |
| STIM | Buy | NEURONETICS INC | $4,504,000 | +40.8% | 295,337 | +78.6% | 0.25% | +18.1% |
| MTLS | Buy | MATERIALISE NVsponsored ads | $4,225,000 | -2.0% | 268,409 | +24.7% | 0.23% | -18.0% |
| AMED | Buy | AMEDISYS INC | $4,148,000 | +40.5% | 33,656 | +33.5% | 0.23% | +17.5% |
| BLUE | Buy | BLUEBIRD BIO INC | $3,634,000 | +183.9% | 23,100 | +79.1% | 0.20% | +138.1% |
| SGEN | Buy | SEATTLE GENETICS INC | $3,354,000 | +69.1% | 45,800 | +30.9% | 0.18% | +42.3% |
| SWAV | New | SHOCKWAVE MED INC | $3,347,000 | – | 100,000 | +100.0% | 0.18% | – |
| EXEL | Buy | EXELIXIS INC | $3,344,000 | +80.9% | 140,500 | +49.5% | 0.18% | +50.8% |
| CVS | Buy | CVS HEALTH CORP | $3,108,000 | +83.7% | 57,627 | +123.1% | 0.17% | +54.1% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $2,787,000 | +79.9% | 103,800 | +8.4% | 0.15% | +50.0% |
| FGEN | Buy | FIBROGEN INC | $2,652,000 | +79.1% | 48,800 | +52.5% | 0.15% | +50.5% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $2,593,000 | +155.5% | 16,300 | +53.8% | 0.14% | +113.4% |
| ARGX | Buy | ARGENX SEsponsored adr | $2,484,000 | +105.3% | 19,900 | +57.9% | 0.14% | +71.2% |
| SYNH | New | SYNEOS HEALTH INCcl a | $2,443,000 | – | 47,200 | +100.0% | 0.13% | – |
| QURE | Buy | UNIQURE NV | $2,285,000 | +693.4% | 38,300 | +283.0% | 0.13% | +563.2% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $2,162,000 | +331.5% | 62,300 | +142.9% | 0.12% | +260.6% |
| ASND | New | ASCENDIS PHARMA A Ssponsored adr | $2,142,000 | – | 18,200 | +100.0% | 0.12% | – |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $2,103,000 | +78.1% | 46,917 | +54.8% | 0.12% | +48.7% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $2,082,000 | +232.6% | 12,353 | +92.1% | 0.12% | +180.5% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL INC | $2,067,000 | +114.2% | 29,800 | +34.2% | 0.11% | +81.0% |
| FOLD | New | AMICUS THERAPEUTICS INC | $2,040,000 | – | 150,000 | +100.0% | 0.11% | – |
| RGNX | Buy | REGENXBIO INC | $1,897,000 | +94.2% | 33,100 | +42.1% | 0.10% | +62.5% |
| PFE | New | PFIZER INC | $1,699,000 | – | 40,000 | +100.0% | 0.09% | – |
| AMRX | Buy | AMNEAL PHARMACEUTICALS INC | $1,417,000 | +10.3% | 100,000 | +5.3% | 0.08% | -7.1% |
| LABD | New | DIREXION SHS ETF TRdaily s&p biotec | $1,380,000 | – | 75,000 | +100.0% | 0.08% | – |
| PTCT | Buy | PTC THERAPEUTICS INC | $1,306,000 | +75.3% | 34,700 | +59.9% | 0.07% | +46.9% |
| RDUS | New | RADIUS HEALTH INC | $1,178,000 | – | 59,100 | +100.0% | 0.06% | – |
| ARRY | New | ARRAY BIOPHARMA INC | $1,175,000 | – | 48,200 | +100.0% | 0.06% | – |
| BNFT | New | BENEFITFOCUS INC | $1,138,000 | – | 22,979 | +100.0% | 0.06% | – |
| PINC | Buy | PREMIER INCcl a | $1,085,000 | +117.0% | 31,462 | +134.8% | 0.06% | +81.8% |
| ZLAB | New | ZAI LAB LTDadr | $885,000 | – | 30,000 | +100.0% | 0.05% | – |
| MDCO | New | MEDICINES CO | $811,000 | – | 29,000 | +100.0% | 0.04% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $663,000 | – | 17,100 | +100.0% | 0.04% | – |
| KURA | New | KURA ONCOLOGY INC | $486,000 | – | 29,300 | +100.0% | 0.03% | – |
| GILD | New | GILEAD SCIENCES INCcall | $174,000 | – | 600 | +100.0% | 0.01% | – |
| GLPG | New | GALAPAGOS NVput | $23,000 | – | 190 | +100.0% | 0.00% | – |
| ABBV | New | ABBVIE INCput | $9,000 | – | 200 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bellevue Asset Management AG #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.